Company Leviathan Cannabis Group Inc Toronto S.E.
Equities
CA61762Y1051
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
98.1
%
| - | - | 35 | 98.1 % | - |
Liquor
1.9
%
| - | - | 1 | 1.9 % | - |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
99.3
%
| 0 | 29.7 % | 34 | 99.3 % | +9,595.03% |
United States
0.7
%
| 1 | 70.3 % | 0 | 0.7 % | -70.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 22-03-06 |
Director of Finance/CFO | - | 22-03-06 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 22-03-06 |
Rupalee Mehta
BRD | Director/Board Member | - | 22-03-06 |
Lucas Leone
BRD | Director/Board Member | - | 22-03-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 117,736,935 | 102,574,682 ( 87.12 %) | 0 | 87.12 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |